Cleveland Clinic Vasculitis Advances and Controversies 2025

Cleveland Clinic Vasculitis Advances and Controversies 2025

 Include: 22 videos + 18 pdfs, size: 10.2 GB

 Target Audience: rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians

Information:

This comprehensive course dives into the complexities and innovations in the treatment and diagnosis of various forms of vasculitis. Participants will critically appraise emergent treatment options for small vessel vasculitis and large vessel vasculitis. In-depth evaluations will explore the central nervous system involvement in vasculitis and the current and future landscape of glucocorticoid use in vasculitis management.

The course will discuss advancements in imaging techniques for large vessel vasculitis and other diagnostic modalities. Participants will appraise the latest diagnostic approaches for giant cell arteritis (GCA), while evaluating the clinical evidence supporting the use of tocilizumab as a first-line therapy in GCA. Additionally, the role of plasma exchange in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis will be thoroughly examined.

By the end of this course, participants will be equipped with the knowledge to effectively evaluate and implement cutting-edge treatments and diagnostic strategies in their practice.

Who Should Attend?

The Symposium is directed towards rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, nurse practitioners, nurses, and physician assistants interested in the treatment of vasculitis.

After completing this course, participants will be able to:

• Critically appraise emergent treatment options in small vessel vasculitis and large vessel vasculitis
• Evaluate CNS involvement in vasculitis
• Evaluate current and future landscape of glucocorticoid use in vasculitis management
• Discuss imaging advancement in large vessel vasculitis and other diagnostic modalities in vasculitis
• Appraise the diagnostic modalities in giant cell arteritis
• Evaluate the clinical evidence supporting the use of tocilizumab as a first-line therapy in GCA
• Appraise the role of plasma exchange in ANCA-associated vasculitis

 Topics:

• 1 Emergent treatment in small vessel vasculitis.pdf
• 1 Emerging treatment in small vessel vasculitis.mp4
• 2 Emergent treatment in large vessel vasculitis.mp4
• 2 Emergent treatment in large vessel vasculitis.pdf
• 3 EGPA – What can I offer to my patients.mp4
• 3 EGPA – What can I offer to my patients.pdf
• 4 Question & Answer.mp4
• 5 Central Nervous System involvement in vasculitis.mp4
• 5 Central Nervous System involvement in vasculitis.pdf
• 6 Ask the Masters Challenging cases in vasculitis.mp4
• 6 Ask the Masters Challenging cases in vasculitis.pdf
• 7 Glucocorticoid use in small vessel vasculitis.mp4
• 7 Glucocorticoid use in small vessel vasculitis.pdf
• 8 Glucocorticoid use in large vessel vasculitis.mp4
• 8 Glucocorticoid use in large vessel vasculitis.pdf
• 9 Question & Answer.mp4
• 10 Large vessel vasculitis imaging.mp4
• 10 Large vessel vasculitis imaging.pdf
• 11 Kidney pathology in small vessel vasculitis.mp4
• 11 Kidney pathology in small vessel vasculitis.pdf
• 12 Pathology in large vessel vasculitis.mp4
• 12 Pathology in large vessel vasculitis.pdf
• 13 Eye exam in giant cell arteritis.mp4
• 13 Eye exam in giant cell arteritis.pdf
• 14 Question & Answer.mp4
• 15 Biopsy or imaging in the diagnosis of giant cell arteritis Tanaz Kermani, MD.mp4
• 15 Biopsy or imaging in the diagnosis of giant cell arteritis Tanaz Kermani, MD.pdf
• 16 Biopsy or imaging in the diagnosis of giant cell arteritis Kinanah Yaseen, MD.mp4
• 16 Biopsy or imaging in the diagnosis of giant cell arteritis Kinanah Yaseen, MD.pdf
• 17 Does plasma exchange have a role in ANCA associated vasculitis Ali Mehdi, MD.mp4
• 17 Does plasma exchange have a role in ANCA associated vasculitis Ali Mehdi, MD.pdf
• 18 Does plasma exchange have a role in ANCA associated vasculitis Alexandra Villa-Forte, MD.mp4
• 18 Does plasma exchange have a role in ANCA associated vasculitis Alexandra Villa-Forte, MD.pdf
• 19 Should Tocilizumab be used in every patient with giant cell arteritis Adam Brown, MD.mp4
• 19 Should Tocilizumab be used in every patient with giant cell arteritis Adam Brown, MD.pdf
• 20 Should Tocilizumab be used in every patient with giant cell arteritis Michael Putman, MD.mp4
• 20 Should Tocilizumab be used in every patient with giant cell arteritis Michael Putman, MD.pdf
• 21 Question & Answer.mp4
• Agenda.pdf
• May 8, 2025.mp4